Amino Acid Tracer (FACBC) Positron Emission Tomography for Lung Nodule
| Status: | Archived |
|---|---|
| Conditions: | Lung Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | May 2009 |
| End Date: | June 2012 |
| Contact: | David Schuster, MD |
| Email: | dschust@emory.edu |
| Phone: | 404-712-4859 |
A Pilot Study of the Utility of the Novel Amino Acid Radiotracer Anti-[18 F]FACBC for the Noninvasive Imaging of Lung Nodules
This study will look at how the [18]FACBC goes into the lung nodules. This will hopefully
lead to the development of better imaging techniques to look at lung nodules. [18]FACBC is
not approved by the FDA (Food and Drug Administration). This study will help to determine if
it should be approved by the FDA.
This is a study that will test a compound (chemical substance) that has a small amount of
radioactivity attached to it. This substance has a natural tendency to go to tumor cells, as
has been shown in the detection and staging of prostate cancer and for brain tumors. In this
study we are going to test this new substance in patients with lung nodules. Lung nodules
are a common finding. It is very important to non-invasively determine whether the nodule is
cancer or not, as early cancer detection and treatment may cure the disease. The substance
is called [18]FACBC and it is given in the form of an injection into a vein. After the
substance reaches the lung nodules, scans called PET or Positron Emission Tomography, are
done. This is similar to having CAT scans or x-rays. Usually a compound called [18]FDG is
used for PET scans but this substance often goes to inflammatory tissues as well. This new
substance does not significantly go to inflammatory tissues, and may allow tumors in the
lungs to be better identified.
We found this trial at
1
site
Emory University Emory University, recognized internationally for its outstanding liberal artscolleges, graduate and professional schools,...
Click here to add this to my saved trials
